Bausch + Lomb Corp

BLCONYSE · USD
16.80USD0.00 (-0.30%)
679

Bausch + Lomb Corp (BLCO) Implied Volatility Current

BLCO implied volatility is 47%. IV Rank is 13%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking BLCO implied volatility helps you identify when options premiums on Bausch + Lomb Corp are historically cheap or expensive, and where the best trades are hiding. Bausch + Lomb Corp implied volatility reflects the market's expectation of future price movement: when BLCO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Bausch + Lomb Corp's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For BLCO, tracking metrics like BLCO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on BLCO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use.

The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where BLCO implied volatility sits today versus where it has been. Our scanner ranks Bausch + Lomb Corp implied volatility against its historical range, surfaces extremes in BLCO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Bausch + Lomb Corp IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
13.49%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)46.74%

IV Rank13.49%

Historical Volatility (30d)18.93%

IV - HV+27.81%

As of September 21, 2026

Trade options with IV on your side

Track BLCO IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial